Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

Background: Several placebo controlled studies have demonstrated the efficacy of infliximab in inflammatory bowel disease (IBD) but the potential toxicity of this new biological compound has been less studied. Aim: To assess the use of infliximab in IBD in a population based cohort, with special emp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ljung, T, Karlén, P, Schmidt, D, Hellström, P M, Lapidus, A, Janczewska, I, Sjöqvist, U, Löfberg, R
Formato: Artigo
Idioma:Inglês
Publicado em: Copyright 2004 by Gut 2004
Assuntos:
Inflammatory Bowel Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1774085/
https://ncbi.nlm.nih.gov/pubmed/15138212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2003.018515
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados